In 2023, hospital discharges for dorsalgia cases in Italy were at 6.1 units per hundred thousand persons. From 2024 to 2028, a declining trend is observed with discharges expected to decrease from 5.7 to 4.3 units. The year-on-year percentage decrease is consistent over the period.
Key Future Trends to Watch For:
- Increasing adoption of telemedicine and outpatient treatment options could further reduce hospital discharges.
- Aging population may impact dorsalgia incidence, potentially increasing demand for medical care.
- Continual advancements in preventive care and physical therapy may contribute to the observed decline in hospital discharges.
Latest reports
US Autoimmune Disease Market Report- Q1 2025
The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...
China Autoimmune Disease Market Report- Q1 2025
The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...
Japan Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...
Germany Autoimmune Disease Market Report- Q4 2024
The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...
UK Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...
South Korea Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...
